Alexander Hardy - Nov 29, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Nov 29, 2024
Transactions value $
-$927,097
Form type
4
Date filed
12/3/2024, 06:15 PM
Previous filing
Mar 19, 2024
Next filing
Mar 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $16.8K +300 +0.2% $56.01 148K Oct 31, 2024 Direct F1
transaction BMRN Common Stock Tax liability -$944K -14.3K -9.63% $66.03 134K Nov 29, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.